Finalists of the Munich Business Plan Competition – Phase 3

These eight teams from Southern Bavaria have made it to the final round

They are developing technologies that transform processes, push boundaries, and rethink entire industries: the nominated startups in Phase 3 of the Munich Business Plan Competition highlight the immense innovative potential rooted in Bavaria. With ideas ranging from novel medical diagnostics for blood cancer to robotics-enabled manufacturing and photonic data processing, they are actively shaping the future – boldly, innovatively, and with a sharp eye on market needs. In this decisive stage, they step into the spotlight and prove how smart concepts can evolve into viable business models. Meet the finalists:

agentix, from the Technical University of Munich, is developing an AI platform that transforms natural language into digital assistants. With its modular multi-agent system, the platform enables SMEs to automate complex business processes – from process definition to the integration of external systems – entirely without coding skills..

BioExoTec, also from the Technical University of Munich, has developed a diagnostic test for the early, non-invasive detection of cancer – using blood or saliva samples. Their solution is 28 times faster and six times more cost-effective than conventional methods, and can also be used for preventive screening or post-treatment monitoring.

Legalian, based in Munich, automates all identity verification processes required for anti-money laundering and compliance regulations. The platform scans international data sources and registries, analyzes risks, and enables secure, scalable, and digital AML checks.

Linque, from Ludwig Maximilian University of Munich, brings photonic integrated circuits into information processing – enabling systems that are up to 25 times more energy-efficient and 10 times faster. Their solutions are designed for high-performance computing, data centers, and edge devices – especially in the context of large-scale AI applications.

Onyx Biotech, based in Vaterstetten, Upper Bavaria, brings precision to pharmaceutical development. Using mathematical models, the team realistically simulates purification processes for complex drug substances like antibodies. What was previously tested primarily through experimentation can now be digitally modeled, saving time, resources, and costs.

OVRLAY, from Grünwald, uses AI and machine learning to turn basic images and videos into high-quality 3D models. Their software solutions, Obsphera360 and ObspheraSTUDIO, help companies create digital twins and marketing assets up to 90% faster and more cost-effectively.

Peak Quantum, a spin-off from the Walther Meißner Institute (BAdW/TUM), builds robust quantum processing units for the next generation of quantum computers. Thanks to their novel architecture, their QPUs are ten times more resilient and significantly more scalable than current models.

Versatile Robotics, an EXIST research transfer project at the German Aerospace Center (DLR), solves a fundamental trade-off in robotics: their control software allows robots to act both powerfully and precisely – without compromising on safety. This breakthrough enables new forms of collaboration between humans, robots, and AI, turning machines into intelligent, versatile partners for the first time.

Von |